Tulane Medical/Cancer Center Minority-Based Community Clinical Oncology Program

描述（由申请人提供）：新奥尔良（NO），路易斯安那州是一个拥有343,000人口的城市，根据2010年人口普查数据（60%黑人，33%高加索人，5%西班牙裔，3%亚洲人）。杜兰医疗中心（包括医学院、医院和诊所）自1834年以来一直提供医疗保健服务。2005年，卡特里娜飓风袭击并摧毁了这座城市的大部分地区，大风和/或洪水花了数周时间才消退。从那时起，许多当地机构重建，包括杜兰大学的癌症研究项目，该项目专门为社区的几个大群体提供服务。这些包括：1)杜兰医疗中心/医院和诊所系统，包括杜兰综合癌症诊所、杜兰路易斯安那州/新奥尔良医疗中心（MCLNO）诊所和杜兰湖畔诊所；2)“医疗之家”计划，以NO的一系列社区诊所为基础；3)当地退伍军人管理局（VA）医院；4)杜兰肿瘤学附属公司，一组区域私人肿瘤学实践。这些事实促使杜兰癌症中心（TCC）的领导层寻求MB-CCOP拨款，以扩大这些人群的临床研究机会。麦克斯韦·e·拉帕姆妇科肿瘤学教授威廉·罗宾逊博士将担任PD/PI，他作为GOG、SWOG和ACTG的研究协调员和现场PI，在临床癌症研究方面取得了长期的成功。内科肿瘤学助理教授Marcelo Blaya博士将担任联合首席研究员，他在NCl合作小组研究方面也拥有丰富的经验。内科助理教授Eboni Price博士将担任癌症预防研究的Co-PD/PI。临床研究副院长Roy Weiner博士将担任副主任，并提供高级领导和建议。Aniko Vigh博士是TCC临床研究办公室主任，并将担任行政/经理。该团队已做好充分准备，可以在其服务的NO社区中成功管理MB-CCOP。

DESCRIPTION (provided by applicant): New Orleans (NO), Louisiana is a city of 343,000, based on 2010 Census data (60% Black, 33% Caucasian, 5% Hispanic, 3% Asian). Tulane Medical Center {including the medical school, hospital and clinic) has provided health care In NO since 1834. In 2005, Hurricane Katrina struck and destroyed most of the city with high winds and/or flood waters that took weeks to subside. Since then, many local institutions have rebuilt, including Tulane's cancer research program, which exclusively provides services to several large segments of the community. These include: 1) the Tulane Medical Center/Hospital and Clinic System, including the Tulane Comprehensive Cancer Clinic, the Tulane Medical Center of Louisiana/New Orleans (MCLNO) clinic, and the Tulane Lakeside Clinic; 2) the "Medical Homes" program, based on a series of neighborhood clinics in NO; 3) the local Veterans Administration (VA) Hospital; and 4) Tulane Oncology Affiliates, a group of regional private oncology practices. These facts have prompted the leadership of Tulane Cancer Center (TCC) to seek an MB-CCOP grant in order to expand access to clinical research in these populations. Dr, William Robinson, Maxwell E. Lapham Professor of Gynecologic Oncology will serve as PD/PI and has a long record of clinical cancer research success as a Study Coordinator and site PI with GOG, SWOG and ACTG. Dr Marcelo Blaya, Assistant Professor, Medical Oncology, will serve as co-PI, and has extensive experience with NCl cooperative group research as well. Dr Eboni Price, Assistant Professor, Internal Medicine, will serve as Co-PD/PI for Cancer Prevention studies. Dr Roy Weiner, Associate Dean of Clinical Research, will serve as Associate PD, and provide senior leadership and advice. Dr Aniko Vigh is the Director of the TCC Clinical Research Office and will serve as Administrator/Manager. This team is well prepared to successfully manage an MB-CCOP in the NO community it serves.